Virtual Reality Versus Intradialytic Neuromuscular Electrical Stimulation on Renin Hormone in Chronic Kidney Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
Worldwide accelerated advances in physical rehabilitation of chronic kidney disease; particularly whom undergoing hemodialysis. Multimodal therapeutic approaches may maximize their recovery through preliminary evidence indicating both intradialytic neuromuscular electrical stimulation or Virtual reality-based rehabilitation (VRBR) is a relatively new method that might make it easier to simulate doing functional tasks than conventional rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 7, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedAugust 12, 2026
August 1, 2026
6 months
August 7, 2026
August 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Renin Hormone test
SIEMENS, Blood Analyzer, Model: DCA Vantage, MPN: 4.6.0.0, USA; Hemostasis system equipment is manufactured by Siemens manumitted company, Germany for both renin hormone test and glomerular filtration rate monitoring among CKD patients collected samples early morning by responsible nursing staff from renal vein through the already inserted catheter/ or directly from patients' veins
At pretreatment At post treatment after 8 weeks of the study protocol
Secondary Outcomes (3)
Shoulder Range of Motion
At pretreatment At posttreatment after 8 weeks of the study protocol
Shoulder muscular strength
At pretreatment At posttreatment after 8 weeks of study protocol
The shoulder pain intensity and functional disability assessment
At pretreatment At posttreatment of 8 weeks of the study protocol
Study Arms (3)
Experimental Group A (Virtual reality)
EXPERIMENTAL20 participants suffering from CKD received Virtual reality by Xbox Kinect 360 console, plus conventional physical therapy protocol, along 8 weeks
Experimental Group B (intradialytic neuromuscular electrical stimulation )
EXPERIMENTAL20 participants suffering from CKD received intradialytic neuromuscular electrical stimulation protocol, for 30 minutes, 3 times per week over 8 weeks.
Experimental Group A (conventional physical therapy protocol including Maitland mobilization)
EXPERIMENTAL20 participants suffering from CKD received Maitland mobilization, plus Conventional physical therapy protocol, along 30-40 minutes, 3 sets/ week over 8 weeks.
Interventions
virtual reality exercise programs that was applied in form of a series of kinect adventure games and designed for Xbox 360 kinect console, and projected onto a 24-inch screen LED-Lit monitor; along 30-40 min, 3 sets/ week along 8 weeks
The portable Chattanooga electric stimulation device has been switched on and adjusted the current amplitude/ strength from 5-140 mA according to each patients' targeted strength, frequency seated at 5Hz over shoulder musculatures under direct supervision along 30 minutes for each session, 3 sessions per week over 8 weeks
maitland graded oscillation technique that was applied to the glenohumeral (GH) joint in form of anteroposterior (A-P), posteroanterior (P-A), and longitudinal caudal glides; as well regarding sternoclavicular joint 'Posterior and anterior glide', plus acromioclavicular joint; anterior glide, only fifteen glides, along 30-40 min, 3 sets/ week along 8 weeks
Active range of motion exercises; along 30-40 min, 3 sets/ week along 8 weeks
Eligibility Criteria
You may qualify if:
- Patient underwent modified radical mastectomy from one month earlier, suffering from shoulder pain and limited range of motion were included in current study.
- Patients' age ranged from 40 to 65 years. Patients of both genders. All patients were free of any comorbidities such as systemic or neurological diseases.
You may not qualify if:
- Patient underwent modified radical mastectomy from one month earlier, suffering from shoulder pain and limited range of motion were included in current study.
- Patients' age ranged from 40 to 65 years. Patients of both genders. All patients were free of any comorbidities such as systemic or neurological diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Adly A Adamlead
Study Sites (1)
Shebin ElKom Teaching Hospital
Cairo, Menofyia, 11432, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Randomized conducted via computerized 'version 25; SPSS Inc., Chicago, Illinois, USA". Each had 1 defining record to assign him/ her into triple equal groups, later were indexing cards in opaque envelopes. Thus,
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Physical Therapy Specialist
Study Record Dates
First Submitted
August 7, 2026
First Posted
August 12, 2026
Study Start
January 1, 2026
Primary Completion
July 1, 2026
Study Completion
August 1, 2026
Last Updated
August 12, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share